← Back to Company DatabaseVisit Website
Harbinger Health
Early cancer detection through novel blood-based biomarkers.
Series ACambridge, MAFounded 2019
About
Harbinger Health is developing a blood test platform for early-stage cancer detection using proprietary biomarker discovery. The company emerged from the Broad Institute and Dana-Farber Cancer Institute with a focus on detecting cancer signals before tumors are visible on imaging. Its approach aims to find cancers at their earliest, most treatable stages.
Total Funding
$140MKey Product
Blood-based early cancer detection platformGeography
North AmericaKey Investors
Flagship Pioneeringa16z BioGV
Focus Areas
Early Detection / ScreeningDiagnostics
Technology
Liquid BiopsyGenomics / SequencingAI / Machine Learning
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026